4//SEC Filing
Plavsic Mark 4
Accession 0001209191-21-066162
CIK 0001434316other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 5:41 PM ET
Size
5.0 KB
Accession
0001209191-21-066162
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technical Officer
Transactions
- Award
Common Stock
2021-11-19+59,540→ 97,540 total
Footnotes (1)
- [F1]These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001868719
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 5:41 PM ET
- Size
- 5.0 KB